Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fishy ads found misleading

This article was originally published in The Tan Sheet

Executive Summary

An omega-3 and -6 supplement ad from manufacturer Equazen misleads consumers to believe the U.K.-based company's eye-q capsules and chews improve all children's school performance even though the study the ad relies on tested the oils on children with developmental coordination disorder and attention deficit hyperactivity disorder, the U.K. Advertising Standards Authority said in an Oct. 15 release. ASA reasoned that even though Equazen listed the study in the ad, readers would infer from the headline "Pay Attention!" and the question, "What will you choose for your child?" that the product could improve all children's attention levels

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102234

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel